Disclosure Of Entity's Operating Segments [Text Block]

Captor Therapeutics S.A. - Filing #6272138

Concept 2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
124 909 869 PLN
2 014 441 PLN
Depreciation and amortisation expense
218 366 PLN
235 089 PLN
Tax expense (income)
9 379 416 PLN
0 PLN
Profit (loss) before tax
73 654 132 PLN
4 165 637 PLN
Profit (loss) from continuing operations
64 274 716 PLN
4 165 637 PLN
Profit (loss)
64 274 716 PLN
0 PLN
64 274 716 PLN
0 PLN
0 PLN
64 274 716 PLN
0 PLN
0 PLN
0 PLN
4 165 637 PLN
4 165 637 PLN
4 165 637 PLN
0 PLN
0 PLN
Assets
153 499 563 PLN
85 687 498 PLN
Liabilities
10 094 812 PLN
6 557 667 PLN
Cash flows from (used in) operating activities
57 435 477 PLN
7 107 936 PLN
Cash flows from (used in) investing activities
8 579 410 PLN
34 846 861 PLN
Cash flows from (used in) financing activities
20 448 366 PLN
24 131 222 PLN
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.